Camber Pharma Launches Generic Sensipar®
Piscataway, NJ, December 10, 2020– Camber Pharmaceuticals is pleased to announce that it has launched Cinacalcet Tablets, which is the generic version of Sensipar®.
Cinacalcet Tablets are used to treat hyperparathyroidism (overactive functioning of the parathyroid glands) in people who are on long-term dialysis for kidney disease.
Cinacalcet Tablets are available from Camber in 30, 60 and 90mg- 30 count bottles.
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






